A cohort study analyzed data from 15,273 men with prostate cancer to determine active surveillance rates at difference points in time.

As robotic techniques continue to evolve, these surgical procedures hold great potential for further transforming cancer treatment and enhancing the quality of care for patients ...

Gifts in Wills fund one-third of Cancer Research UK’s work. Work that supports life-saving trials for people like Alfred.

Prostate cancer waiting times could be radically cut by an 'extremely encouraging' 20 minute test, scientists have revealed.

Elisabeth Potter, a doctor based in Austin, Texas, created a video on Instagram detailing her experience treating a cancer ...

Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration for its use ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...